Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill

被引:89
作者
Braun, Andrea B.
Litonjua, Augusto A. [2 ,3 ]
Moromizato, Takuhiro [1 ]
Gibbons, Fiona K. [4 ]
Giovannucci, Edward [5 ,6 ]
Christopher, Kenneth B. [1 ]
机构
[1] Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Pulm & Crit Care Div, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Div Pulm, Boston, MA 02114 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
acute kidney injury; intensive care; RIFLE criteria; vitamin D; REGULATORY T-CELLS; ISCHEMIA-REPERFUSION INJURY; ACUTE-RENAL-FAILURE; NF-KAPPA-B; INTENSIVE-CARE-UNIT; MEDIATED TISSUE PROTECTION; VITAMIN-D LEVELS; RIFLE CRITERIA; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3; HOSPITAL MORTALITY;
D O I
10.1097/CCM.0b013e318260c928
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Given the importance of inflammation in acute kidney injury and the relationship between vitamin D and inflammation, we sought to elucidate the effect of vitamin D on acute kidney injury. We hypothesized that deficiency in 25-hydroxyvitamin D prior to hospital admission would be associated with acute kidney injury in the critically ill. Design: Two-center observational study of patients treated in medical and surgical intensive care units. Setting: Two hundred nine medical and surgical intensive care beds in two teaching hospitals in Boston, Massachusetts. Patients: Two thousand seventy-five patients, aged >= 18 yrs, in whom serum 25-hydroxyvitamin D was measured prior to hospitalization between 1998 and 2009. Interventions: None. Measurements and Main Results: The exposure of interest was preadmission serum 25-hydroxyvitamin D and categorized a priori as deficiency (25-hydroxyvitamin D <= 15 ng/mL), insufficiency (25-hydroxyvitamin D 15-30 ng/mL), or sufficiency (25-hydroxyvitamin D >= 30 ng/mL). The primary outcome was acute kidney injury defined as meeting Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) Injury or Failure criteria. Logistic regression examined the RIFLE criteria outcome. Adjusted odds ratios were estimated by multivariate logistic regression models. Preadmission 25-hydroxyvitamin D deficiency is predictive of acute kidney injury. Patients with 25-hydroxyvitamin D deficiency have an odds ratio for acute kidney injury of 1.73 (95% confidence interval 1.30-2.30; p < .0001) relative to patients with 25-hydroxyvitamin D sufficiency. 25-Hydroxyvitamin D deficiency remains a significant predictor of acute kidney injury following multivariable adjustment (adjusted odds ratio 1.50; 95% confidence interval 1.42-2.24; p < .0001). Patients with 25-hydroxyvitamin D insufficiency have an odds ratio for acute kidney injury of 1.49 (95% confidence interval 1.15-1.94; p = .003) and an adjusted odds ratio of 1.23 (95% confidence interval 1.12-1.72; p = .003) relative to patients with 25-hydroxyvitamin D sufficiency. In addition, preadmission 25-hydroxyvitamin D deficiency is predictive of mortality. Patients with 25-hydroxyvitamin D insufficiency have an odds ratio for 30-day mortality of 1.60 (95% confidence interval 1.18-2.17; p = .003) and an adjusted odds ratio of 1.61 (95% confidence interval 1.06-1.57; p = .004) relative to patients with 25-hydroxyvitamin D sufficiency. Conclusion: Deficiency of 25-hydroxyvitamin D prior to hospital admission is a significant predictor of acute kidney injury and mortality in a critically ill patient population. (Crit Care Med 2012; 40:3170-3179)
引用
收藏
页码:3170 / 3179
页数:10
相关论文
共 121 条
[31]   METABOLISM - NEW APPROACHES TO VITAMIN-D [J].
DICKSON, I .
NATURE, 1987, 325 (6099) :18-18
[32]   Regulatory T cells: a brake on ischemic injury or an active promoter of tissue healing? [J].
Ferenbach, David A. ;
Kluth, David C. ;
Hughes, Jeremy .
KIDNEY INTERNATIONAL, 2009, 76 (07) :689-691
[33]   Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury [J].
Gandolfo, Maria Teresa ;
Jang, Hye Ryoun ;
Bagnasco, Serena M. ;
Ko, Gang-Jee ;
Agreda, Patricia ;
Satpute, Shailesh R. ;
Crow, Michael T. ;
King, Landon S. ;
Rabb, Hamid .
KIDNEY INTERNATIONAL, 2009, 76 (07) :717-729
[34]   25-hydroxyvitamin D and risk of myocardial infarction in men - A prospective study [J].
Giovannucci, Edward ;
Liu, Yan ;
Hollis, Bruce W. ;
Rimm, Eric B. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (11) :1174-1180
[35]   Vitamin D insufficiency and deficiency in chronic kidney disease -: A single center observational study [J].
González, EA ;
Sachdeva, A ;
Oliver, DA ;
Martin, KJ .
AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (05) :503-510
[36]   A 1α,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice [J].
Gregori, S ;
Giarratana, N ;
Smiroldo, S ;
Uskokovic, M ;
Adorini, L .
DIABETES, 2002, 51 (05) :1367-1374
[37]   Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance [J].
Gregori, S ;
Casorati, M ;
Amuchastegui, S ;
Smiroldo, S ;
Davalli, AM ;
Adorini, L .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :1945-1953
[38]   Transcription factor-κB (NF-κB) and renal disease [J].
Guijarro, C ;
Egido, J .
KIDNEY INTERNATIONAL, 2001, 59 (02) :415-424
[39]   1,25-dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: Implications for prevention of diabetes in nonobese diabetic mice [J].
Gysemans, CA ;
Cardozo, AK ;
Callewaert, H ;
Giulietti, A ;
Hulshagen, L ;
Bouillon, R ;
Eizirik, DL ;
Mathieu, C .
ENDOCRINOLOGY, 2005, 146 (04) :1956-1964
[40]  
Heine G, 2002, EUR J IMMUNOL, V32, P3395, DOI 10.1002/1521-4141(200212)32:12<3395::AID-IMMU3395>3.0.CO